{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/patient-centric-practices-ad#webpage",
"url": "https://www.fortrea.com/insights/patient-centric-practices-ad",
"name": "Patient-centric practices for AD",
"description": "Explore how Alzheimer’s disease clinical trials address patient recruitment challenges, enrollment barriers, and retention complexities in dementia research. Learn how Alzheimer’s patient recruitment strategies and site-based approaches help improve participation in clinical trials for Alzheimer’s. Explore how caregiver engagement in clinical trials plays a critical role in supporting patients and improving adherence throughout the study lifecycle. Learn how patient centric Alzheimer’s clinical trials and diversity-focused strategies enhance inclusion while reducing burden in Alzheimer’s studies. By applying best practices in dementia clinical research, including improved retention strategies and patient-focused design, organizations can strengthen trial execution and improve outcomes in Alzheimer’s disease clinical trials."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Patient-centric practices for AD",
"item": "https://www.fortrea.com/insights/patient-centric-practices-ad"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry - as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/patient-centric-practices-ad#article",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/patient-centric-practices-ad#webpage"
},
"headline": "Alzheimer’s Disease Clinical Trials and Patient Recruitment Strategies | Fortrea Insights",
"description": "Explore how Alzheimer’s disease clinical trials address patient recruitment challenges, enrollment barriers, and retention complexities in dementia research. Learn how Alzheimer’s patient recruitment strategies and site-based approaches help improve participation in clinical trials for Alzheimer’s. Explore how caregiver engagement in clinical trials plays a critical role in supporting patients and improving adherence throughout the study lifecycle. Learn how patient centric Alzheimer’s clinical trials and diversity-focused strategies enhance inclusion while reducing burden in Alzheimer’s studies. By applying best practices in dementia clinical research, including improved retention strategies and patient-focused design, organizations can strengthen trial execution and improve outcomes in Alzheimer’s disease clinical trials.",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-10-14",
"dateModified": "2024-10-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-10/IS_0053_Best%20Practices%20Alzheimers_1123.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/patient-centric-practices-ad#webpage",
"url": "https://www.fortrea.com/insights/patient-centric-practices-ad",
"name": "Patient-centric practices for AD",
"description": "Explore how Alzheimer’s disease clinical trials address patient recruitment challenges, enrollment barriers, and retention complexities in dementia research. Learn how Alzheimer’s patient recruitment strategies and site-based approaches help improve participation in clinical trials for Alzheimer’s. Explore how caregiver engagement in clinical trials plays a critical role in supporting patients and improving adherence throughout the study lifecycle. Learn how patient centric Alzheimer’s clinical trials and diversity-focused strategies enhance inclusion while reducing burden in Alzheimer’s studies. By applying best practices in dementia clinical research, including improved retention strategies and patient-focused design, organizations can strengthen trial execution and improve outcomes in Alzheimer’s disease clinical trials."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Patient-centric practices for AD",
"item": "https://www.fortrea.com/insights/patient-centric-practices-ad"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry - as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/patient-centric-practices-ad#article",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/patient-centric-practices-ad#webpage"
},
"headline": "Alzheimer’s Disease Clinical Trials and Patient Recruitment Strategies | Fortrea Insights",
"description": "Explore how Alzheimer’s disease clinical trials address patient recruitment challenges, enrollment barriers, and retention complexities in dementia research. Learn how Alzheimer’s patient recruitment strategies and site-based approaches help improve participation in clinical trials for Alzheimer’s. Explore how caregiver engagement in clinical trials plays a critical role in supporting patients and improving adherence throughout the study lifecycle. Learn how patient centric Alzheimer’s clinical trials and diversity-focused strategies enhance inclusion while reducing burden in Alzheimer’s studies. By applying best practices in dementia clinical research, including improved retention strategies and patient-focused design, organizations can strengthen trial execution and improve outcomes in Alzheimer’s disease clinical trials.",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-10-14",
"dateModified": "2024-10-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-10/IS_0053_Best%20Practices%20Alzheimers_1123.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
Article